NGM bags $107M from an IPO de­signed to back their play in the big NASH R&D race

Key­ing off some en­cour­ag­ing pre­lim­i­nary Phase II da­ta for NASH and a long­stand­ing col­lab­o­ra­tion with Mer­ck that has gen­er­at­ed hun­dreds of mil­lions of dol­lars in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER